- Report
- October 2024
- 186 Pages
Global
From €3402EUR$3,545USD£2,835GBP
€3780EUR$3,939USD£3,150GBP
- Report
- March 2025
- 50 Pages
Global
From €2543EUR$2,650USD£2,119GBP
Carbasalate Calcium is a type of animal pharmaceutical used to treat a variety of conditions in animals, including pain relief, inflammation, and fever. It is a non-steroidal anti-inflammatory drug (NSAID) that works by blocking the production of certain chemicals in the body that cause inflammation. It is commonly used in veterinary medicine to treat a variety of conditions, including arthritis, joint pain, and fever. It is also used to treat certain types of cancer in animals.
Carbasalate Calcium is available in a variety of forms, including tablets, capsules, and injectable solutions. It is typically administered orally or intravenously, depending on the condition being treated. It is generally considered safe for use in animals, although it can cause side effects such as vomiting, diarrhea, and loss of appetite.
The Carbasalate Calcium market is a growing segment of the animal pharmaceuticals industry. It is used to treat a variety of conditions in animals, and is becoming increasingly popular due to its effectiveness and safety.
Some companies in the Carbasalate Calcium market include Boehringer Ingelheim, Merck Animal Health, Elanco Animal Health, and Zoetis. Show Less Read more